The Educational Branch of COLONTOWN

COLONTOWN University

COLONTOWN University

Latest DocTalks

Briefs 🩲

Short videos from your favorite DocTalks

See all Briefs →

Evolving role of HER2/ERBB2 targeting in CRC: 2026 Updates: Dr. Raghav (2026)

COLONTOWN Presents: CRS-HIPEC patient experiences and decision making for colorectal cancer peritoneal metastases: Drs. Godfrey & Kopecky (2026)

Liver Met Formation and How HAIP Can Help: The UCSF Experience and Research Insight: Dr. Maker (2024)

COLONTOWN Presents: AI and Your Cancer Care: Where Hope Meets Technology: Dr. Loaiza-Bonilla (2025)

All DocTalks

All
CtDNA
Immunotherapy
Trials
Biomarkers
Liver

Liver Met Formation and How HAIP Can Help: The UCSF Experience and Research Insight: Dr. Maker (2024)

CHALLENGE Trial: Dr. Gill (2025)

Histotripsy: New Technology for Liver Tumor Treatment: Dr. Burns (2025)

BOT+BAL trial for MSS CRC: Dr. DeVito (2025)

Targeting KRAS for Patients with CRC: Dr. Sahin (2025)

Understanding Your Biomarker Report: Dr. Strickler (2025)

Advancements in Liver Transplant Oncology for Stage IV CRC: Dr. Satish Nadig (2025)

HAI Physician & Patient Panel: Drs. Ellis & Turk (2025)

CAR-T and Other Novel Immunotherapy for Colorectal Cancer: Dr. Keenan (2025)

BRAF Poster: Dr Maddelena (2025)

OrigAMI-1: Dr. Kanwal Raghav (2025)

Multimodal Management of Liver Mets: Dr. Rocca (2025)

Recent results from the GALAXY trial – Dr. Stacey Cohen (2024)

KRAS G12C trial: Dr. Parseghian (2024)

Clinical trials demystified, part 3: Dr. Allegra, Dr. Wright & Dr. Weinstock (2024)

LIVER LOVERS Legend: Dr. Yuman Fong on All Things Liver (2024)

Y90 for CRC liver mets — What patients need to know: Dr. Dayyani (2024)

SBRT for liver and lung mets: Dr. Miller (2024)

Liver transplants — Examining the evidence: Dr. Hernandez-Alejandro (2024)

Early-stage BRAF V600E MSS colon cancer — What’s next after adjuvant treatment: Dr. Yaeger (2024)

Evolving role of HER2/ERBB2 targeting in CRC: 2026 Updates: Dr. Raghav (2026)

COLONTOWN Presents: CRS-HIPEC patient experiences and decision making for colorectal cancer peritoneal metastases: Drs. Godfrey & Kopecky (2026)

Liver Met Formation and How HAIP Can Help: The UCSF Experience and Research Insight: Dr. Maker (2024)

COLONTOWN Presents: AI and Your Cancer Care: Where Hope Meets Technology: Dr. Loaiza-Bonilla (2025)

CRC Updates from ESMO25: Dr. Hornstein (2025)

CHALLENGE Trial: Dr. Gill (2025)

Evolving role of HER2/ERBB2 targeting in CRC: 2026 Updates: Dr. Raghav (2026)

COLONTOWN Presents: CRS-HIPEC patient experiences and decision making for colorectal cancer peritoneal metastases: Drs. Godfrey & Kopecky (2026)

Liver Met Formation and How HAIP Can Help: The UCSF Experience and Research Insight: Dr. Maker (2024)

COLONTOWN Presents: AI and Your Cancer Care: Where Hope Meets Technology: Dr. Loaiza-Bonilla (2025)

CRC Updates from ESMO25: Dr. Hornstein (2025)

CHALLENGE Trial: Dr. Gill (2025)

Evolving role of HER2/ERBB2 targeting in CRC: 2026 Updates: Dr. Raghav (2026)

COLONTOWN Presents: CRS-HIPEC patient experiences and decision making for colorectal cancer peritoneal metastases: Drs. Godfrey & Kopecky (2026)

Liver Met Formation and How HAIP Can Help: The UCSF Experience and Research Insight: Dr. Maker (2024)

COLONTOWN Presents: AI and Your Cancer Care: Where Hope Meets Technology: Dr. Loaiza-Bonilla (2025)

CRC Updates from ESMO25: Dr. Hornstein (2025)

CHALLENGE Trial: Dr. Gill (2025)

Evolving role of HER2/ERBB2 targeting in CRC: 2026 Updates: Dr. Raghav (2026)

COLONTOWN Presents: CRS-HIPEC patient experiences and decision making for colorectal cancer peritoneal metastases: Drs. Godfrey & Kopecky (2026)

Liver Met Formation and How HAIP Can Help: The UCSF Experience and Research Insight: Dr. Maker (2024)

COLONTOWN Presents: AI and Your Cancer Care: Where Hope Meets Technology: Dr. Loaiza-Bonilla (2025)

CRC Updates from ESMO25: Dr. Hornstein (2025)

CHALLENGE Trial: Dr. Gill (2025)

Evolving role of HER2/ERBB2 targeting in CRC: 2026 Updates: Dr. Raghav (2026)

COLONTOWN Presents: CRS-HIPEC patient experiences and decision making for colorectal cancer peritoneal metastases: Drs. Godfrey & Kopecky (2026)

Liver Met Formation and How HAIP Can Help: The UCSF Experience and Research Insight: Dr. Maker (2024)

COLONTOWN Presents: AI and Your Cancer Care: Where Hope Meets Technology: Dr. Loaiza-Bonilla (2025)

CRC Updates from ESMO25: Dr. Hornstein (2025)

CHALLENGE Trial: Dr. Gill (2025)

Evolving role of HER2/ERBB2 targeting in CRC: 2026 Updates: Dr. Raghav (2026)

COLONTOWN Presents: CRS-HIPEC patient experiences and decision making for colorectal cancer peritoneal metastases: Drs. Godfrey & Kopecky (2026)

Liver Met Formation and How HAIP Can Help: The UCSF Experience and Research Insight: Dr. Maker (2024)

COLONTOWN Presents: AI and Your Cancer Care: Where Hope Meets Technology: Dr. Loaiza-Bonilla (2025)

CRC Updates from ESMO25: Dr. Hornstein (2025)

CHALLENGE Trial: Dr. Gill (2025)